These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route,380380-64-3, its application will become more common.
Reference of 380380-64-3 ,Some common heterocyclic compound, 380380-64-3, molecular formula is C7H6BrN5, its traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc., below Introduce a new synthetic route.
To a 5 -L, three-neck, round-bottom flask was charged 4 (200.0 g, 0.833 mol) followed by 1,4-dioxane (3 L, 15 vol). Crude compound 6 (361.2 g, 1.249 mol, 1.5 equiv.), Pd2(dba)3 (11.44 g, 0.0125 g, 0.015 equiv.), and PCy3 (7.0 g, 0.025 mol, 0.03 equiv.) was charged and degassed with nitrogen for 30 minutes. A solution Of K2CO3 (195.7 g, 1.7 equiv.) in water (800 mL, 4 vol) was charged, and the reaction was heated to 70 0C. The reaction was complete after 1 hour with 0.5 area % of 4 remaining. The reaction was cooled to 50 0C, and Darco G-60 (40 g, 0.2 wt) was added and stirred for 30 minutes. Celite 545 (40 g, 0.2 wt) was charged and then the reaction was filtered through Celite 545 (100 g, 0.5 wt) wetted with water (300 mL). The hot filtration into the water from the Celite caused precipitation of the product. Tetrahydrofuran (1.2 L, 6 vol) and brine (600 mL, 3 vol) were added, and the product re-dissolved at room temperature. The phase split was accomplished cleanly (Vmax = 28 volumes). The dioxane was concentrated and ethanol (1 L, 5 vol) was added and concentrated. Then the product was reslurried in ethanol: water (4: 1, 2 L, 10 vol) at 700C, cooled to room temperature over 3 hours, filtered and washed with ethanol (2 x 400 mL). Compound 7 was isolated in 87% yield (292.6 g) with a purity of 97.7 % (AUC) by HPLC analysis. The 1H NMR and 19F NMR indicated the presence of one compound. Pd analysis showed 135 ppm Pd was in the product.
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route,380380-64-3, its application will become more common.
Reference:
Patent; TRIUS THERAPEUTICS; COSTELLO, Carrie, A.; SIMSON, Jaqueline, A.; DUGUID, Robert, J.; PHILLIPSON, Douglas; WO2010/42887; (2010); A2;,
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem